RITUXIMAB

作品数：228被引量：444H指数：10
导出分析报告
相关领域：医药卫生更多>>
相关作者：杨志张岩林保和朱华王雪鹃更多>>
相关机构：北京大学肿瘤医院北京协和医院第二军医大学中山大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金广东省自然科学基金国家高技术研究发展计划国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Advances in the pathophysiology and treatment of focal segmental glomerulosclerosis:The importance of a timely and tailored approach
《World Journal of Nephrology》2025年第2期1-8,共8页Guido Gembillo Concetto Sessa Domenico Santoro 
Focal segmental glomerulosclerosis(FSGS)is a histological pattern of glomerular damage that significantly contributes to chronic kidney disease and end-stage renal disease.Its incidence is rising globally,necessitatin...
关键词：Focal segmental glomerulosclerosis Chronic kidney disease GLOMERULONEPHRITIS Renal failure Immunosuppressive therapy Calcineurin inhibitors Mycophenolate mofetil RITUXIMAB Sparsentan PLASMAPHERESIS 
Septic shock due to cytomegalovirus colitis associated with rituximab use:A case report
《World Journal of Virology》2025年第1期118-123,共6页Siddharth Patel Jordan Jay Prutha Pathak Mc Anto Antony Mrudula Thiriveedi 
BACKGROUND Cytomegalovirus(CMV)infections can cause significant morbidity and mortality in immunocompromised individuals.CMV targets dysfunctional lymphocytes.Chronic rituximab(RTX)therapy can cause B-lymphocyte dysfu...
关键词：Cytomegalovirus colitis Rituximab use Immunocompromised status Septic shock PANCYTOPENIA Case report 
Evaluation of biological therapies in autoimmune hepatitis:A casebased systematic review
《World Journal of Gastrointestinal Pathophysiology》2025年第1期1-13,共13页Haifa Eldew Jonathan Soldera 
BACKGROUND Autoimmune hepatitis(AIH)is typically treated with immunomodulators and steroids.However,some patients are refractory to these treatments,necessitating alternative approaches.Biological therapies have recen...
关键词：Autoimmune hepatitis Biological therapies BELIMUMAB RITUXIMAB BASILIXIMAB INFLIXIMAB ADALIMUMAB 
Four-Year Maintenance Therapy with Cyclosporin A for Patients with Steroid-Refractory Idiopathic Minimal Change Disease Allergic to Rituximab
《Open Journal of Nephrology》2024年第4期538-544,共7页Kamel El-Reshaid Shaikha Al-Bader Hossameldin Tawfik Sallam John Patrick Madda 
Background: Patients with Steroid-Refractory Idiopathic Minimal change disease (SRIM) have high morbidity and mortality and inherent side effects of immunosuppressive therapy. Except for its cost, R has been shown to ...
关键词：CORTICOSTEROIDS Cyclosporin A RITUXIMAB Nephrotic Syndrome Minimal Change Disease Maintenance Therapy 
IgG4 Disease Revealed by Renal Damage: Report of a Series of Cases
《Open Journal of Internal Medicine》2024年第4期329-336,共8页N’Guessan Michel Konan Pascal Sanou Manzan Edwige Anastasie Wognin Tiepe Rokia Ouattara Georges Stéphane Koffi Jean-Fiacre Lidwine Abbot Christ Zahe Reine Marie Koffi Abdoul Yannick Gonan Kehi Jonathan Kpan Ahua N’Seliosseh Sébastienne Yao Weu Mélanie Tia Yao Hubert Kouamé Bourahima Ouattara Lionel Rostaing 
IgG4 disease is an immune-mediated disorder characterized by fibroinflammatory masses that can infiltrate multiple organ systems. Renal involvement is considered one of the key features of this disease. Report 02 case...
关键词：IgG4 Disease Extramembranous Glomerulonephritis Tubulo-Nephritis Interstitial Corticotherapie RITUXIMAB 
Efficacy and prognostic analysiss of rituximab in the treatment of M-type phospholipase A2 receptor-associated idiopathic membranous nephropathy
《China Medical Abstracts(Internal Medicine)》2024年第4期225-226,共2页CHEN Jia 
Objective To investigate the efficacy and prognosis of rituximab(RTX)in the treatment of M-type phospholipase A2 receptor(PLA2R)-associated idiopathic membranous nephropathy(IMN).Methods It was a retrospective cohort ...
关键词：MEMBRANOUS NEPHROPATHY TREATMENT 
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
《Signal Transduction and Targeted Therapy》2024年第10期4554-4563,共10页Zhiyong Zeng Apeng Yang Jingke Yang Sheng Zhang Zhen Xing Xingfu Wang Wenzhong Mei Changzhen Jiang Junfang Lin Xiyue Wu Yihui Xue Zanyi Wu Lianghong Yu Dengliang Wang Jianwu Chen Shufa Zheng Qiaoxian Lin Qingjiao Chen Jinfeng Dong Xiaoqiang Zheng Jizhen Wang Jinlong Huang Zhenying Chen Ping Chen Meihong Zheng Xiaofang Zhou Youwen He Yuanxiang Lin Junmin Chen 
https://doi.org/10.1038/s41392-024-01941-x Fujian Provincial Health Technology Project[grant number 2023CXA028];Joint Funds for the Innovation of Science and Technology,Fujian Province(grant number 2023Y9021);National Science Foundation of Fujian Province[grant number 2022J02036];Clinical research project of Wu Jieping Medical Foundation[grant number 320.6750.19094-41];National Natural Science Foundation of China[grant number 82070218,81400160].
Primary central nervous system lymphoma(PCNSL)is a rare and frequently fatal lymphoma subtype.The programmed death-1(PD-1)pathway has emerged as a potential therapeutic target,but the effectiveness of PD-1 antibody si...
关键词：METHOTREXATE LYMPHOMA system 
Rituximab Induced Vasculitis: Dose the Antigen-Antibody Complex of Rituximab Play a Role in Developing Leukocytoclastic Vasculitis?—A Case Report and Review of the Literature
《Journal of Biosciences and Medicines》2024年第9期89-94,共6页Ahmed A. AlTaroti Zahra Z. AlZahir Salah Abohelaika 
Rituximab is a monoclonal antibody that targets CD20, which is a specific B-cell surface antigen. It was the first monoclonal antibody that was approved for the treatment of non-Hodgkin lymphoma, rheumatoid arthritis,...
关键词：Rheumatoid Arthritis RITUXIMAB VASCULITIS Leukocytoclastic Vasculitis 
Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus:A retrospective study
《World Journal of Nephrology》2024年第4期81-90,共10页Elvira Kalashnikova Eugenia Isupova Ekaterina Gaidar Natalia Lubimova Lyubov Sorokina Irina Chikova Maria Kaneva Rinat Raupov Olga Kalashnikova Damir Aliev Inna Gaydukova Mikhail Kostik 
Supported by Ministry of Science and Higher Education of the Russian Federation,No.075-15-2022-301;the Russian Science Foundation Grant,No.22-45-08004.
BACKGROUND Juvenile systemic lupus erythematosus(SLE)is a severe,life-threatening disease.However,the role of rituximab in managing juvenile SLE remains undefined,although early biological intervention may improve dis...
关键词：Systemic lupus erythematosus RITUXIMAB Rituximab BCD020 biosimilar Anti-CD-20 BIOLOGIC Children 
Combination therapy with methylprednisolone,rituximab,and tofacitinib in antimelanoma differentiation-associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease
《Rheumatology & Autoimmunity》2024年第2期122-125,共4页Mona Manghani Weiyen Lim Gin Tsen Chai Xin Rong Lim Choon Guan Chua 
To the Editor,Anti-melanoma differentiation-associated gene 5(anti-MDA5)antibody-associated dermatomyositis(DM)presenting with rapidly progressive interstitial lung disease(RP-ILD)is extremely challenging to treat.MDA...
关键词：INTERFERON melanoma lung 
全选清除导出
共23页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部